Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation

Mostrar otras versiones (1)

The use of the lipid lowering agent niacin is hampered by a frequent flush response which is largely mediated by prostaglandin (PG) D(2). Therefore, concomitant administration of the D-type prostanoid (DP) receptor antagonist laropiprant has been proposed to be a useful approach in preventing niacin...

Descripción completa

Detalles Bibliográficos
Autores principales: Philipose, Sonia, Konya, Viktoria, Lazarevic, Mirjana, Pasterk, Lisa M., Marsche, Gunther, Frank, Sasa, Peskar, Bernhard A., Heinemann, Akos, Schuligoi, Rufina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411562/
https://www.ncbi.nlm.nih.gov/pubmed/22870195
http://dx.doi.org/10.1371/journal.pone.0040222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411562/
https://www.ncbi.nlm.nih.gov/pubmed/22870195
http://dx.doi.org/10.1371/journal.pone.0040222

Ejemplares similares